Duncan Barbara Gayle - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Duncan Barbara Gayle
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-10-23
Sale
2020-10-23
5:32 pm
IMMUNOMEDICS INCIMMUDuncan Barbara Gayle
Director
49,244$0$00
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-06-20
Option Award
2025-06-24
6:05 pm
N/A
N/A
Atea Pharmaceuticals Inc.AVIRDuncan Barbara Gayle
Director
70,800$0133,550
(Direct)
View
2025-06-20
Exercise
2025-06-24
6:05 pm
N/A
N/A
Atea Pharmaceuticals Inc.AVIRDuncan Barbara Gayle
Director
29,600$0133,550
(Direct)
View
2025-02-20
Option Award
2025-06-18
4:45 pm
N/A
2035-02-19
Ovid Therapeutics Inc.OVIDDuncan Barbara Gayle
Director
45,000$045,000
(Direct)
View
2025-05-01
Option Award
2025-05-02
4:04 pm
N/A
2035-05-01
HALOZYME THERAPEUTICS INC.HALODuncan Barbara Gayle
Director
9,915$025,669
(Direct)
View
2024-12-12
Option Award
2024-12-16
4:15 pm
N/A
2034-12-11
Ovid Therapeutics Inc.OVIDDuncan Barbara Gayle
Director
90,000$090,000
(Direct)
View
2024-06-21
Option Award
2024-06-21
6:12 pm
N/A
N/A
Atea Pharmaceuticals Inc.AVIRDuncan Barbara Gayle
Director
70,800$070,800
(Direct)
View
2024-06-16
Exercise
2024-06-18
5:00 pm
N/A
N/A
Atea Pharmaceuticals Inc.AVIRDuncan Barbara Gayle
Director
33,150$033,150
(Direct)
View
2024-04-25
Option Award
2024-04-29
5:54 pm
N/A
2034-04-25
HALOZYME THERAPEUTICS INC.HALODuncan Barbara Gayle
Director
15,305$024,558
(Direct)
View
2024-02-22
Option Award
2024-02-26
5:54 pm
N/A
2034-02-21
Ovid Therapeutics Inc.OVIDDuncan Barbara Gayle
Director
30,000$030,000
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:05 pm
N/A
N/A
Atea Pharmaceuticals Inc.AVIRDuncan Barbara Gayle
Director
79,900$079,900
(Direct)
View
2023-06-14
Option Award
2023-06-14
5:06 pm
N/A
2033-06-13
Fusion Pharmaceuticals Inc.FUSNDuncan Barbara Gayle
Director
17,000$017,000
(Direct)
View
2023-05-05
Option Award
2023-05-09
6:16 pm
2024-05-05
2033-05-05
HALOZYME THERAPEUTICS INC.HALODuncan Barbara Gayle
Director
19,436$020,624
(Direct)
View
2023-02-23
Option Award
2023-02-27
4:47 pm
N/A
2033-02-22
Ovid Therapeutics Inc.OVIDDuncan Barbara Gayle
Director
15,000$015,000
(Direct)
View
2023-02-03
Option Award
2023-02-07
4:06 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALODuncan Barbara Gayle
Director
1,188$01,188
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:01 pm
2023-07-01
2032-07-01
Adaptimmune Therapeutics PLCADAPDuncan Barbara Gayle
Director
500,000$0500,000
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:02 pm
N/A
2032-06-24
Jounce Therapeutics Inc.JNCEDuncan Barbara Gayle
Director
20,000$020,000
(Direct)
View
2022-06-14
Option Award
2022-06-22
7:07 pm
N/A
2032-06-13
Fusion Pharmaceuticals Inc.FUSNDuncan Barbara Gayle
Director
17,000$017,000
(Direct)
View
2022-06-17
Option Award
2022-06-21
7:49 pm
N/A
2032-06-16
Atea Pharmaceuticals Inc.AVIRDuncan Barbara Gayle
Director
61,264$061,264
(Direct)
View
2022-04-08
Option Award
2022-04-12
4:55 pm
N/A
2032-04-07
Ovid Therapeutics Inc.OVIDDuncan Barbara Gayle
Director
21,347$021,347
(Direct)
View
2022-02-03
Option Award
2022-02-04
8:48 pm
N/A
2032-02-02
Ovid Therapeutics Inc.OVIDDuncan Barbara Gayle
Director
15,000$015,000
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:00 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLCADAPDuncan Barbara Gayle
Director
379,788$0379,788
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:45 pm
N/A
2031-06-18
Jounce Therapeutics Inc.JNCEDuncan Barbara Gayle
Director
15,700$015,700
(Direct)
View
2021-06-18
Option Award
2021-06-21
5:35 pm
N/A
2031-06-17
Atea Pharmaceuticals Inc.AVIRDuncan Barbara Gayle
Director
34,025$034,025
(Direct)
View
2021-06-11
Option Award
2021-06-11
8:31 pm
N/A
2031-06-10
Ovid Therapeutics Inc.OVIDDuncan Barbara Gayle
Director
15,000$015,000
(Direct)
View
2021-06-04
Option Award
2021-06-07
4:14 pm
N/A
2031-06-03
Fusion Pharmaceuticals Inc.FUSNDuncan Barbara Gayle
Director
17,000$017,000
(Direct)
View
2021-05-17
Option Award
2021-05-18
8:57 pm
N/A
2031-05-16
Ovid Therapeutics Inc.OVIDDuncan Barbara Gayle
Director
1,750$01,750
(Direct)
View
2020-10-30
Option Award
2020-11-03
4:56 pm
N/A
2030-10-29
Fusion Pharmaceuticals Inc.FUSNDuncan Barbara Gayle
Director
30,000$030,000
(Direct)
View
2020-10-29
Option Award
2020-10-30
5:49 pm
N/A
2030-10-28
Atea Pharmaceuticals Inc.AVIRDuncan Barbara Gayle
Director
80,000$080,000
(Direct)
View